Literature DB >> 2562941

Immunopathogenic mechanisms of HIV infection.

Z F Rosenberg1, A S Fauci.   

Abstract

The acquired immunodeficiency syndrome (AIDS) follows infection with the human immunodeficiency virus (HIV) after a long and variable period of time. Although HIV can be rapidly cytopathic in vitro for T4 cells, during early in vivo infection, T4 cell numbers are normal and few infected T4 cells can be found. There is increasing evidence that cells of the monocyte/macrophage lineage, including bone marrow precursor cells, can be infected by HIV and are relatively resistant to the cytopathic effects of the virus. As in other lentivirus infections, the monocyte/macrophage may serve as a reservoir of HIV in the body and may play a major role in the pathogenesis of AIDS. In vitro induction of HIV from a latent or low level chronic infection to an active state results from exposure to physiologic cellular inductive signals that might be encountered during normal immune responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562941     DOI: 10.1016/0090-1229(89)90122-0

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

1.  In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats.

Authors:  A Hein; J P Martin; R Dörries
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.

Authors:  Masakazu Kamata; Patrick Y Kim; Hwee L Ng; Gene-Errol E Ringpis; Emiko Kranz; Joshua Chan; Sean O'Connor; Otto O Yang; Irvin S Y Chen
Journal:  Biochem Biophys Res Commun       Date:  2015-05-19       Impact factor: 3.575

3.  Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.

Authors:  Masakazu Kamata; Shirley Liu; Min Liang; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  Hum Gene Ther       Date:  2010-10-06       Impact factor: 5.695

4.  HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand.

Authors:  Lin Zheng; Yida Yang; Lu Guocai; C David Pauza; Maria S Salvato
Journal:  Intervirology       Date:  2007-03-14       Impact factor: 1.763

5.  Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system.

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

6.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

Review 7.  Requirement for prooxidant and antioxidant states in T cell mediated immune responses.--Relevance for the pathogenetic mechanisms of AIDS?

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Klin Wochenschr       Date:  1991-12-15

8.  Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects.

Authors:  F Capsoni; F Minonzio; A M Ongari; G Colombo; G P Rizzardi; P Bonara; A D'Arminio-Monforte; C Zanussi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

Authors:  I L Noronha; V Daniel; K Schimpf; G Opelz
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

10.  Personalized life expectancy and treatment benefit index of antiretroviral therapy.

Authors:  Yanni Xiao; Xiaodan Sun; Sanyi Tang; Yicang Zhou; Zhihang Peng; Jianhong Wu; Ning Wang
Journal:  Theor Biol Med Model       Date:  2017-01-18       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.